Anthony Strzalek
Important to utilise DCBs with strongest possible data behind them
NOTE: This video is ONLY available to watch in selected countries and geographies
Tuomas Ri...
Transcatheter options for AR open up TAVI to a new patient population
Transcatheter treatment options for aortic regurgitation (AR) bring a new, less invasive approa...
AHA 2022: First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients with high-quality great saphenous vein
The first results from the BEST-CLI randomised controlled trial (RCT) of 1,830 patients show tha...
Edwards’ Pascal Precision transcatheter valve repair system receives FDA approval for degenerative mitral regurgitation
Edwards Lifesciences has announced that its Pascal Precision transcatheter valve repair system for t...
Key learnings from Manta device study to be presented at TCT
Teleflex has announced that Magnus Settergren, associate professor at the Karolinska Institutet, int...
Why ClotTriever is a “gamechanger” for the treatment of deep vein thrombosis
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) discuss the current sta...
NICE recommends new treatment to reduce stroke and heart attack deaths
The National Institute for Health and Care Excellence (NICE) has recommended the use of VAZKEPA ...
ESC 2021: Systematic pressure wire assessment has no additional benefit at diagnostic angiography
Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not redu...
ESC 2021: TOMAHAWK trial does not support early coronary angiography in cardiac arrest without ST elevation
Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment ...
ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI
Edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients wi...
ESC 2021: One-month dual antiplatelet therapy post-stent implant benefits high bleeding risk patients
One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk...
Randomised trials “instrumental” in future research of tricuspid valve repair
Speaking to Cardiovascular News, Georg Nickenig (Bonn, Germany) details the presentation of a u...
EXPAND registry outcomes of new MitraClip devices in line with COAPT
Jörg Hausleiter (Munich, Germany) talks to Cardiovascular News about the one-year findings of ...
Onyx ONE sub-analysis shows higher cardiac death for P2Y12 inhibitor compared to aspirin following DAPT
Azeem Latib (New York, USA) spoke to Cardiovascular News about a sub-analysis of the Onyx ONE st...
One-year TRILUMINATE trial data “a tremendous boost to the field of transcatheter interventions”
Philipp Lurz (Leipzig, Germany) speaks to Cardiovascular News about the TRILUMINATE tr...
Selecting the right valve for the patient is key for a successful TAVI program
NOTE: This video is ONLY available to watch in selected countries and geographies
Azeem Latib ...
First-in-human results show no transcaval-related bleeding after TAVR with novel closure device
Toby Rogers (Washington,DC, USA) tells Cardiovascular News that preliminary feasibility data fro...
